Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cantabria Labs is a leading international pharmaceutical company specializing in dermatology and advanced skin care solutions. The company is widely recognized for its Heliocare brand, which utilizes the patented Fernblock technology to provide comprehensive oral and topical photoprotection against UV-induced damage. In addition to sun care, Cantabria Labs develops innovative therapeutic lines such as Endocare for skin regeneration, Biretix for acne management, and Neoretin for pigment control. Headquartered in Madrid, Spain, the company operates a state-of-the-art, eco-sustainable manufacturing facility and maintains a presence in over 80 countries. Their commitment to scientific research and clinical validation has established them as a key player in the global cosmeceutical and dermatological markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heliocare regional distributors.